ALK-Abello A/S

Industry

  • In Vitro Diagnostics
  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
  • Biotechnology

Other Names/Subsidiaries

  • ALK-Abelló
  • Allergy Laboratories
  • Inc.
  • Crystal Laboratory LLC
  • ALK-Scherax Arzneimittel
  • Allerbio
  • American Biopol
  • Epipharm
  • Artu Biologicals
See more in Biomedtracker

Latest on ALK-Abello A/S

Scrip

Deal Watch: Sarepta Targets RNAi In Broad Collaboration With Arrowhead

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sarepta Obtains Rights To Seven Arrowh

Scrip

Novartis’s Peanut Allergy Setback Perks Up Rivals

 
• By Kevin Grogan

The news that Novartis AG has terminated a late-stage peanut allergy trial of one of its more closely watched assets, ligelizumab, looks like good news for other players in the space, notably DBV T

Scrip

Can Denmark's ALK-Abello Crack The US Allergy Market?

 
• By John Davis

Denmark's allergy therapies company, ALK-Abello AS , has become the latest European-headquartered firm to outline a corporate strategy that includes plans to crack the US allergists market, aiming

Scrip

DBV Technologies Misses With Viaskin Peanut Allergy Patch

 
• By Alex Shimmings

DBV Technologies SA patch therapy for peanut allergy Viaskin Peanut missed the primary endpoint in its Phase III PETITES study, sending the company's share price down on NASDAQ by 46% to $25.95 on